Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Change in Account Payables: 2011-2024

Historic Change in Account Payables for Veracyte (VCYT) over the last 14 years, with Dec 2024 value amounting to -$4.3 million.

  • Veracyte's Change in Account Payables fell 194.21% to -$3.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.9 million, marking a year-over-year increase of 41.82%. This contributed to the annual value of -$4.3 million for FY2024, which is 3112.69% down from last year.
  • Per Veracyte's latest filing, its Change in Account Payables stood at -$4.3 million for FY2024, which was down 3,112.69% from -$134,000 recorded in FY2023.
  • In the past 5 years, Veracyte's Change in Account Payables registered a high of $5.2 million during FY2021, and its lowest value of -$4.3 million during FY2024.
  • Over the past 3 years, Veracyte's median Change in Account Payables value was -$134,000 (recorded in 2023), while the average stood at -$1.4 million.
  • Per our database at Business Quant, Veracyte's Change in Account Payables soared by 625.04% in 2021 and then plummeted by 3,112.69% in 2024.
  • Veracyte's Change in Account Payables (Yearly) stood at $711,000 in 2020, then skyrocketed by 625.04% to $5.2 million in 2021, then slumped by 97.05% to $152,000 in 2022, then crashed by 188.16% to -$134,000 in 2023, then slumped by 3,112.69% to -$4.3 million in 2024.